GlysetActive Ingredient(s): Miglitol
FDA Approved: * December 18, 1996
Pharm Company: * PHARMACIA AND UPJOHN
Miglitol is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to break down complex carbohydrates into glucose. It is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body. Miglitol, and other structurally-related iminosugars, inhibit glycoside hydrolase e... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
miglitol for diabetes from drug group alpha gulucosidose inhibitors...